Brief: HLS Therapeutics Announces Updates To Its Board Of Directors
22/06/2023 11:36
June 22 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES UPDATES TO ITS BOARD OF
DIRECTORS
* HLS THERAPEUTICS INC: JOHN WELBORN, JR. IS APPOINTED CHAIR
OF
BOARD, SUCCEEDING GREG GUBITZ, WHO IS RETIRING
* HLS THERAPEUTICS INC: JOHN HANNA IS APPOINTED TO HLS BOARD
AS AN
INDEPENDENT DIRECTOR
Source text for Eikon: ID:nCNW0tmmNa
Further company coverage: HLS.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group